• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Metabolic and anthropometric consequences of interruption of highly active antiretroviral therapy.

作者信息

Hatano H, Miller K D, Yoder C P, Yanovski J A, Sebring N G, Jones E C, Davey R T

机构信息

Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institute of Health, Bethesda, Maryland 20892-1880, USA.

出版信息

AIDS. 2000 Sep 8;14(13):1935-42. doi: 10.1097/00002030-200009080-00008.

DOI:10.1097/00002030-200009080-00008
PMID:10997397
Abstract

BACKGROUND

HAART has been associated with metabolic abnormalities (hyperlipidemia, insulin resistance, alterations in cortisol metabolism) and fat redistribution.

SETTING

A prospective study of 26 Caucasian men (median age 43.5 years) with HIV-1 viral loads < 500 copies/ml for 12 months while on highly active antiretroviral therapy (HAART) who interrupted treatment for a median of 7.0 weeks (range 4.9-10.3 weeks). Seventeen (65.4%) patients reported at least one fat redistribution symptom at baseline.

METHOD

Serum lipids, glucose and insulin levels during an oral glucose tolerance test, 24-h urinary free cortisol and 17-hydroxycorticosteroids, and anthropometric parameters were measured before HAART cessation and prior to its reinstitution.

RESULTS

When baseline values were compared with those obtained after HAART interruption (means +/- SD), there was a significant decrease in total cholesterol (194+/-47.3 versus 159+/-29.3 mg/dl; P < 0.0001), low density lipoprotein (LDL) cholesterol (114+/-32.6 versus 96+/-24.7 mg/dl; P = 0.0013), triglycerides (261+/-244.3 versus 185+/-165.4 mg/dl; P = 0.008), and 24-hour urinary 17-hydroxycorticosteroids (15+/-7.9 versus 5+/-2.5 mg/24 h, P < 0.0001) and a significant increase in 24-hour urinary free cortisol (45+/-34.1 versus 62+/-32.2 microg/24 h; P = 0.016). There were no significant changes in glucose or insulin levels or in anthropometric measurements.

CONCLUSIONS

A relatively brief interruption of HAART resulted in significant improvements in total cholesterol, LDL cholesterol, and triglyceride levels. No changes were observed in insulin resistance profiles or anthropometric measurements, perhaps because of the brief duration of HAART interruption. These results suggest that hyperlipidemia and alterations in corticosteroid metabolism in the setting of HAART are a direct drug effect that reverses with drug withdrawal. However, glucose metabolism and fat redistribution do not change over the short term.

摘要

相似文献

1
Metabolic and anthropometric consequences of interruption of highly active antiretroviral therapy.
AIDS. 2000 Sep 8;14(13):1935-42. doi: 10.1097/00002030-200009080-00008.
2
Substituting abacavir for hyperlipidemia-associated protease inhibitors in HAART regimens improves fasting lipid profiles, maintains virologic suppression, and simplifies treatment.在高效抗逆转录病毒治疗(HAART)方案中,用阿巴卡韦替代与高脂血症相关的蛋白酶抑制剂可改善空腹血脂状况,维持病毒学抑制效果,并简化治疗。
BMC Infect Dis. 2005 Jan 12;5:2. doi: 10.1186/1471-2334-5-2.
3
Impact of protease inhibitor substitution with efavirenz in HIV-infected children: results of the First Pediatric Switch Study.用依非韦伦替代蛋白酶抑制剂对HIV感染儿童的影响:首次儿科换药研究结果
Pediatrics. 2003 Mar;111(3):e275-81. doi: 10.1542/peds.111.3.e275.
4
Lipodystrophic syndromes and hyperlipidemia in a cohort of HIV-1-infected patients receiving triple combination antiretroviral therapy with a protease inhibitor.接受含蛋白酶抑制剂的三联抗逆转录病毒疗法的一组HIV-1感染患者中的脂肪营养不良综合征和高脂血症
J Acquir Immune Defic Syndr. 2001 Aug 15;27(5):443-9. doi: 10.1097/00126334-200108150-00004.
5
Changes in body habitus and serum lipid abnormalities in HIV-positive women on highly active antiretroviral therapy (HAART).接受高效抗逆转录病毒治疗(HAART)的HIV阳性女性的身体形态变化和血清脂质异常
J Acquir Immune Defic Syndr. 1999 Jun 1;21(2):107-13.
6
Reversion of metabolic abnormalities after switching from HIV-1 protease inhibitors to nevirapine.
AIDS. 1999 May 7;13(7):805-10. doi: 10.1097/00002030-199905070-00009.
7
Marked dyslipidemia in human immunodeficiency virus-infected children on protease inhibitor-containing antiretroviral therapy.接受含蛋白酶抑制剂的抗逆转录病毒疗法的人类免疫缺陷病毒感染儿童出现明显血脂异常。
Pediatrics. 2002 Nov;110(5):e56. doi: 10.1542/peds.110.5.e56.
8
Clinical lipoatrophy in HIV-1 patients on HAART is not associated with increased abdominal girth, hyperlipidaemia or glucose intolerance.接受高效抗逆转录病毒治疗(HAART)的HIV-1患者出现的临床脂肪萎缩与腹围增加、高脂血症或葡萄糖不耐受无关。
HIV Med. 2002 Oct;3(4):239-46. doi: 10.1046/j.1468-1293.2002.00125.x.
9
Diabetes, insulin resistance and dyslipidaemia in lipodystrophic HIV-infected patients on highly active antiretroviral therapy (HAART).接受高效抗逆转录病毒治疗(HAART)的脂肪营养不良型HIV感染患者的糖尿病、胰岛素抵抗和血脂异常。
Diabetes Metab. 1999 Sep;25(3):225-32.
10
Lipid profiles for antiretroviral-naive patients starting PI- and NNRTI-based therapy in the Swiss HIV cohort study.在瑞士HIV队列研究中,初治抗逆转录病毒治疗患者开始基于蛋白酶抑制剂(PI)和非核苷类逆转录酶抑制剂(NNRTI)治疗时的血脂谱。
Antivir Ther. 2005;10(5):585-91.

引用本文的文献

1
Treatment of dyslipidemia in HIV.HIV患者血脂异常的治疗。
Curr Atheroscler Rep. 2015 Apr;17(4):493. doi: 10.1007/s11883-015-0493-x.
2
HIV and HAART-Associated Dyslipidemia.HIV与高效抗逆转录病毒治疗相关的血脂异常
Open Cardiovasc Med J. 2011;5:49-63. doi: 10.2174/1874192401105010049. Epub 2011 Feb 24.
3
Changes in lipids and lipoprotein particle concentrations after interruption of antiretroviral therapy.抗逆转录病毒治疗中断后血脂和脂蛋白颗粒浓度的变化。
J Acquir Immune Defic Syndr. 2010 Jul;54(3):275-84. doi: 10.1097/qai.0b013e3181d32158.
4
The effects of intermittent, CD4-guided antiretroviral therapy on body composition and metabolic parameters.间歇、CD4 指导的抗逆转录病毒治疗对身体成分和代谢参数的影响。
AIDS. 2010 Jan 28;24(3):353-63. doi: 10.1097/QAD.0b013e3283333666.
5
Subjective clinical lipoatrophy assessment correlates with DEXA-measured limb fat.主观临床脂肪萎缩评估与双能X线吸收法测量的肢体脂肪相关。
HIV Clin Trials. 2009 Sep-Oct;10(5):314-9. doi: 10.1310/hct1005-314.
6
Approach to the human immunodeficiency virus-infected patient with lipodystrophy.对患有脂肪代谢障碍的人类免疫缺陷病毒感染患者的治疗方法。
J Clin Endocrinol Metab. 2008 Aug;93(8):2937-45. doi: 10.1210/jc.2008-1019.
7
HIV-associated lipodystrophy syndrome: A review of clinical aspects.HIV 相关脂肪代谢障碍综合征:临床方面综述。
Can J Infect Dis Med Microbiol. 2005 Jul;16(4):233-43. doi: 10.1155/2005/303141.
8
Plastic surgical approaches for HIV-associated lipoatrophy.针对与艾滋病相关脂肪萎缩的整形外科手术方法。
Curr HIV/AIDS Rep. 2005 Aug;2(3):127-31. doi: 10.1007/s11904-005-0005-7.
9
Cardiovascular implications of HIV-associated dyslipidemic lipodystrophy.
Curr Atheroscler Rep. 2004 May;6(3):173-9. doi: 10.1007/s11883-004-0029-2.
10
The cellular structure and lipid/protein composition of adipose tissue surrounding chronically stimulated lymph nodes in rats.大鼠慢性刺激淋巴结周围脂肪组织的细胞结构和脂质/蛋白质组成。
J Anat. 2003 Jun;202(6):551-61. doi: 10.1046/j.1469-7580.2003.00188.x.